Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 5/20 | 0.42 |
| ▸ | CISD2 | Q8N5K1 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12326381 | 0.84 | KDM4E (0.51) | ALDH1A1KDM4EPOLBGAAHSD17B10 | |
| SCHEMBL15733279 | 0.84 | KDM4E (0.45) | ALDH1A1KDM4EHPGDPOLBGAA | |
| SCHEMBL28853045 | 0.83 | KDM4E (0.36) | ALDH1A1KDM4EHPGDPOLBGAA | |
| SCHEMBL15733357 | 0.83 | ADORA2A (0.46) | ALDH1A1KDM4EHPGDGAACISD2 | |
| SCHEMBL16411023 | 0.83 | KDM4E (0.54) | ALDH1A1KDM4EHPGDPOLBGAA | |
| SCHEMBL19783127 | 0.83 | KDM4E (0.44) | ALDH1A1KDM4EHPGDPOLBGAA | |
| SCHEMBL16411014 | 0.83 | KDM4E (0.44) | ALDH1A1KDM4EHPGDPOLBGAA | |
| SCHEMBL14397086 | 0.82 | KDM4E (0.43) | ALDH1A1KDM4EHPGDPOLBGAA | |
| SCHEMBL951068 | 0.81 | KDM4E (0.59) | KDM4EGPR35 | |
| SCHEMBL21990971 | 0.81 | KDM4E (0.42) | ALDH1A1KDM4EHPGDGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024176261-A1 | A PROCESS FOR PREPARATION OF ANTHRANILAMIDE COMPOUND AND INTERMEDIATE THEREOF | UPL LIMITED (IN) | 2024-08-29 | — | — | WO | disclosed |
| US-20240067624-A1 | PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES | UPL LTD (IN) | 2024-02-29 | — | — | US | disclosed |
| US-20240067624-A1 | PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES | UPL LTD (IN) | 2024-02-29 | — | — | US | disclosed |
| US-20240067624-A1 | PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES | UPL LTD (IN) | 2024-02-29 | — | — | US | disclosed |
| CN-116496460-B | Covalent organic framework material, ligand and application thereof | 吉林省卓材新研科技有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116730977-A | Novel aryl heterocyclic compound, and preparation method and application thereof | 华东理工大学 | 2023-09-12 | — | — | CN | disclosed |
| CN-116724015-A | Process for preparing insecticidal anthranilamides | UPL有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-116496460-A | Covalent organic framework material, ligand and application thereof | 吉林省卓材新研科技有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20230088326-A1 | PROCESS FOR PREPARATION OF ARTHROPODICIDAL ANTHRANILAMIDE COMPOUNDS | UPL LTD (IN) | 2023-03-23 | — | — | US | disclosed |
| CN-115279746-A | Process for preparing arthropodicidal anthranilamide compounds | UPL有限公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-2729462-B1 | METHOD FOR MANUFACTURING TETRAZOLE SUBSTITUTED ANTHRANILIC ACID DERIVATIVES BY CONVERTING PYRAZOLE ACIDS WITH ANTHRANILIC ACID ESTERS | BAYER IP GMBH (DE) | 2017-10-04 | — | — | EP | disclosed |
| EP-2729444-B1 | METHOD FOR MANUFACTURING 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | BAYER IP GMBH (DE) | 2017-08-23 | — | — | EP | disclosed |
| US-9169198-B2 | Method for the production of 2-amino-5-cyano-N,3-dimethylbenzamide | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-10-27 | — | — | US | disclosed |
| US-8916710-B2 | Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting pyrazolic acids with anthranilic acid esters | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-12-23 | — | — | US | disclosed |
| US-20140235865-A1 | METHOD FOR PRODUCING TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVES BY REACTING PYRAZOLIC ACIDS WITH ANTHRANILIC ACID ESTERS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-08-21 | — | — | US | disclosed |
| US-20140148611-A1 | METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-05-29 | — | — | US | disclosed |
| EP-2729462-A1 | METHOD FOR PRODUCING TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVES BY REACTING PYRAZOLIC ACIDS WITH ANTHRANILIC ACID ESTERS | Bayer Intellectual Property GmbH (DE) | 2014-05-14 | — | — | EP | disclosed |
| EP-2729444-A1 | METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | Bayer Intellectual Property GmbH (DE) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013007604-A1 | METHOD FOR PRODUCING TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVES BY REACTING PYRAZOLIC ACIDS WITH ANTHRANILIC ACID ESTERS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-17 | — | — | WO | disclosed |
| WO-2013007603-A1 | METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148611-A1 | METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE | ALKBH5, ALKBH2, MMAB | ALDH1A1 1505/4885KDM4E 124/4885HPGD 858/4885 |
| US-20240067624-A1 | PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES | ANTXR2, NAAA, AGPS | ALDH1A1 1498/4885KDM4E 1624/4885HPGD 442/4885 |
| US-20230088326-A1 | PROCESS FOR PREPARATION OF ARTHROPODICIDAL ANTHRANILAMIDE COMPOUNDS | ANTXR2, APEH, TYR | ALDH1A1 1202/4885KDM4E 1445/4885HPGD 686/4885 |
| US-20140235865-A1 | METHOD FOR PRODUCING TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVES BY REACTING PYRAZOLIC ACIDS WITH ANTHRANILIC ACID ESTERS | DAO, QPCT, AADAT | ALDH1A1 969/4885KDM4E 1968/4885HPGD 1223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.